QR Kod

Systemic adjuvant and perioperative chemotherapy following curative-intent liver metastasectomy in colorectal cancer—is it justified?

Colorectal liver metastases (CRLM) pose a significant challenge in oncological care, with surgical resection offering the best chance for long-term survival. Despite curative-intent liver metastasectomy, recurrence rates remain high, underscoring the need for effective adjuvant therapies. While adju...

Ful tanımlama

Kaydedildi:
Asıl Yazarlar: R.D. Peixoto, J.M. Loree, T.A. Miranda, J.P. Solar Vasconcelos, D.J. Renouf, J.M. Davies, K. Gill, S. Gill, V. Poon, C. Metcalf, M. Chahal, M.S. Bleszynski, M. Segedi, P.T.W. Kim, H.J. Lim
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2025-09-01
Seri Bilgileri:ESMO Gastrointestinal Oncology
Konular:
colorectal cancer
liver metastases
metastasectomy
adjuvant chemotherapy
perioperative chemotherapy
Online Erişim:http://www.sciencedirect.com/science/article/pii/S2949819825000597
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller